tiprankstipranks

Neil Kumar Insider Profile

4 Followers
Neil Kumar, CEO, Director, Ten Percent Owner at Eidos Therapeutics, holds 6.91M shares in BridgeBio Pharma (Ticker: BBIO), holds 24.58M shares in Eidos Therapeutics (Ticker: EIDX).
tipranks
Neil Kumar

Neil Kumar
Eidos Therapeutics (EIDX)
CEO, Director, Ten Percent Owner

Ranked #32,896 out of 99,541 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+6.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$188M
100.00%
A breakdown of Neil Kumar's holdings

Insider Roles

BridgeBio Pharma
(BBIO)
CEO & President, Director
Roles that Neil Kumar holds in companies

Most Profitable Insider Trade

Stock:
Eidos Therapeutics
(EIDX)
Rating:Informative Buy
Date:May 29, 2019 - May 29, 2020
Return:+57.20%
The most profitable trade made by Neil Kumar

Neil Kumar's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
EIDX
Eidos Therapeutics
Jul 08, 2019
Informative Buy
26.38M
$3.00B
BridgeBio Pharma
May 17, 2024
CEO & President, Director
Uninformative Buy
928.69K
$188.05M
List of latest transactions for each holding click on a transaction to see Neil Kumar's performance on stock

Neil Kumar insider profile FAQ

What is the percentage of profitable transactions made by Neil Kumar?
The percentage of profitable transactions made by Neil Kumar is 75%.
    What is the average return per transaction made by Neil Kumar?
    The average return per transaction made by Neil Kumar is 6.80%.
      What stocks does Neil Kumar hold?
      Neil Kumar holds: EIDX, BBIO stocks.
        What was Neil Kumar’s latest transaction?
        Neil Kumar latest transaction was an Uninformative Buy of $928.69K.
          What was Neil Kumar's most profitable transaction?
          Neil Kumar’s most profitable transaction was an Informative Buy of EIDX stock on May 29, 2019. The return on the trade was 57.20%.
            What is Neil Kumar's role in Eidos Therapeutics?
            Neil Kumar's role in Eidos Therapeutics is CEO, Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.